Thromboembolism and bleeding in systemic amyloidosis: a review

Abstract The assessment of both thromboembolic and haemorrhagic risks and their management in systemic amyloidosis have been poorly emphasized so far. This narrative review summarizes main evidence from literature with clinical perspective. The rate of thromboembolic events is as high as 5–10% amylo...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:ESC Heart Failure
المؤلفون الرئيسيون: Martin Nicol, Virginie Siguret, Giuseppe Vergaro, Alberto Aimo, Michele Emdin, Jean Guillaume Dillinger, Mathilde Baudet, Alain Cohen‐Solal, Camille Villesuzanne, Stephanie Harel, Bruno Royer, Bertrand Arnulf, Damien Logeart
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Wiley 2022-02-01
الموضوعات:
Amyloidosis
Thromboembolism
Bleeding
Anticoagulative therapy
الوصول للمادة أونلاين:https://doi.org/10.1002/ehf2.13701

الانترنت

https://doi.org/10.1002/ehf2.13701

مواد مشابهة